Phase II study of neoadjuvant carboplatin and paclitaxel followed by radiotherapy and concurrent cisplatin in patients with locoregionally advanced nasopharyngeal carcinoma: Therapeutic monitoring with plasma Epstein-Barr virus DNA
Publication in refereed journal


Times Cited
Web of Science80WOS source URL (as at 15/11/2020) Click here for the latest count
Altmetrics Information
.

Other information
AbstractPurpose To assess the efficacy of neoadjuvant paclitaxel and carboplatin (TC) followed by concurrent cisplatin and radiotherapy (RT) in patients with locoregionally advanced nasopharyngeal carcinoma (NPC) and to monitor treatment response with plasma Epstein-Barr virus (EBV) DNA.
All Author(s) ListChan ATC, Ma BBY, Lo D, Leung SF, Kwan WH, Hui EP, Mok TSK, Kam M, Chan LS, Chiu SKW, Yu KH, Cheung KY, Lai K, Lai M, Mo F, Yeo W, King A, Johnson PJ, Teo PML, Zee B
Name of Conference38th Annual Meeting of the American-Society-of-Clinical-Oncology
Start Date of Conference18/05/2002
End Date of Conference21/05/2002
Place of ConferenceORLANDO
Journal nameJournal of Clinical Oncology
Year2004
Month8
Day1
Volume Number22
Issue Number15
PublisherAMER SOC CLINICAL ONCOLOGY
Pages3053 - 3060
ISSN0732-183X
eISSN1527-7755
LanguagesEnglish-United Kingdom
Web of Science Subject CategoriesOncology; ONCOLOGY

Last updated on 2020-16-11 at 01:23